APOE and atherosclerosis: In 2001, researchers found that IL-18-binding protein, an IL-18 inhibitor, could not only attenuate the progress of plaque formation in the aorta but also decrease lymphocyte infiltration and lipid content in the lesion, thus exerting protective effects against atherosclerosis on Apoe−/− mice [18].